Regulatory Story
Go to market news section View chart   Order free annual report   Print
Company GlaxoSmithKline PLC
TIDM GSK
Headline

Total Voting Rights

Released 12:07 02-Apr-2013
Number 3307B12

RNS Number : 3307B
GlaxoSmithKline PLC
02 April 2013
 



 

 

 

 

 

 

 

 

Total Voting Rights and Capital

 

In conformity with Disclosure and Transparency Rule 5.6.1R, GlaxoSmithKline plc (the Company) hereby notifies the market of the following:

 

The Company's issued share capital as at 28 March 2013 consisted of 5,407,676,569 Ordinary Shares of 25p each, of which 498,081,327 Ordinary Shares were held in Treasury.

 

Therefore, the total number of voting rights in the Company is 4,909,595,242. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Services Authority's Disclosure and Transparency Rules.

 

 

 

V A Whyte

Company Secretary

 

2 April 2013

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TVRUGUCUCUPWGGP
Close
London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.

Total Voting Rights - RNS